🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our latest newsletter has landed! 📰💥Please sure to take a 👀& kindly re-tweet. bit.ly/4fWweYk National Cancer Audit Collaborating Centre Healthcare Quality Improvement Partnership LymphomaAction The Leukemia & Lymphoma Society Blood Cancer UK Blood Cancer Alliance BSH - Haematology David Cutter Oxford Centre for Haematology YHHN_UK Kate Walker HaemSTAR 💙 Jill Stoddart Peter Johnson

We are delighted to share a short blog which has been prepared by our Patient and Public Involvement Chair, Frank Burroughs. Please do take a look. bit.ly/3ANCOQP #BCAM National Cancer Audit Collaborating Centre LymphomaAction Blood Cancer UK Blood Cancer Alliance BSH - Haematology David Cutter Healthcare Quality Improvement Partnership

The NNHLA Quality Improvement Plan has landed! The plan sets out: ⭐️5 QI goals ⭐️11 performance indicators Read the full report here bit.ly/3AKNvmX LymphomaAction The Leukemia & Lymphoma Society Blood Cancer UK BSH - Haematology Anthony Nolan Healthcare Quality Improvement Partnership Jill Stoddart David Cutter Kate Walker

Exciting news! ⭐️The first NNHLA State of the Nation report is out tomorrow! Check this space or the National Cancer Audit Collaborating Centre webpages for details bit.ly/3TkRE7J #BCAM LymphomaAction Blood Cancer UK The Leukemia & Lymphoma Society Anthony Nolan Healthcare Quality Improvement Partnership NHS England David Cutter Macmillan Cancer Support Matt Ahearne

📢💥It's here! We are delighted to share our first State of the Nation report; along with a number of supplementary materials. Our thanks to everyone involved in its development. bit.ly/3XmI5q7 Healthcare Quality Improvement Partnership LymphomaAction Blood Cancer UK David Cutter Kate Walker

Watch this space! 👀Our latest NNHLA quarterly report is out tomorrow. We won't spoil the surprise, but we've been working on some changes and this time something is different!..... 🤫🏥📊🔎 Healthcare Quality Improvement Partnership Jill Stoddart Blood Cancer UK LymphomaAction BSH - Haematology David Cutter

We promised you something exciting was coming... Our first quarterly report which includes clinical performance indicators & is presented on a new,highly interactive dashboard! 💥 bit.ly/3Ni3PyL Healthcare Quality Improvement Partnership LymphomaAction Blood Cancer UK David Cutter Kate Walker #NHL

Excited to be here at #ISHL13 , come along Sunday at 3pm for my talk about our registry analysis David Cutter and swing by our posters regarding translational analysis of the ANIMATE study and our data collection project HoOP Graham Collins #hodgkinlymphoma

Fascinating - the hospital at which a patient with Hodgkin lymphoma is treated in England has more effect on the variation in radiotherapy usage than sex of the patient. Suggests standardisation of approach is not yet achieved! #ISHL13 #lymsm. David Cutter David Jones

Great presentation by Aisling Barrett on the NHSE dataset of older pts with Hodgkin lymphoma. ABVD assoc with best outcomes but of course used in fitter pts. Profound impact of age, PS, comorbidities in this age group. #ISHL13 #lymsm

Steve Ansell highlighting late effects of our treatment. No ‘safe dose’ of dox with respect to cardiac toxicity. Good data for dexrazoxane cardio protection with no evidence of ‘tumour protection’. #ISHL13 #lymsm

Abscopal effect does exist in #Hodgkin lymphoma when RT 20Gy is given to PD-1 treated patiens. New distant responses seen outside RT fields. Pembro-RT an option in R/R HL with limited disease #ISHL13 #lymsm dr Christian Bauses. Also safe with RT with low doses! AERN trial !

Thanks to Rajana Advani for including our data in the Best of #ISHL13 session. What a phenomenal three days- so much exciting science and practice-changing trial data, and so many new friends made with exciting future collaboration potential.

Moving beyond mean heart dose: The importance of cardiac substructures in radiation therapy toxicity. onlinelibrary.wiley.com/doi/full/10.11…

Having learned every BSH - Haematology guideline off by heart for my FRCPath, it was very exciting to have been afforded the opportunity to lead an amazing group of co-authors for our GPP regarding bleomycin use in Hodgkin Lymphoma- published today! onlinelibrary.wiley.com/doi/10.1111/bj…

📢Our latest newsletter provides updates on: State of the Nation reporting, our Quarterly Clinical Performance Indicator report, the recent National Cancer Audit Collaborating Centre webinar & details of the latest report from Blood Cancer UK 📰 bit.ly/4i2c1Br Healthcare Quality Improvement Partnership LymphomaAction Edward Pinches #NHL

Out this week, this new publication explores how the distribution of trial site locations, may lead to disparities in patient representation in clinical trials. bit.ly/416VENC David Cutter LymphomaAction Blood Cancer UK National Cancer Audit Collaborating Centre Wiley NHS England Healthcare Quality Improvement Partnership

📄📣 Analyzing >10,000 patients treated in randomized GHSG trials, we show strong correlation of PFS and OS after Hodgkin lymphoma first-line treatment across risk groups Annals of Oncology doi.org/10.1016/j.anno…! Great GHSG team effort Bastian von Tresckow Uniklinikum Essen Uniklinik Köln 🎉

View the latest NNHLA Quarterly Data Dashboard here: bit.ly/4j21CpP Healthcare Quality Improvement Partnership Jill Stoddart Lymphoma Hub The Leukemia & Lymphoma Society LymphomaAction Lymphoma Research Foundation David Cutter NHS England Anthony Nolan Blood Cancer UK Blood Cancer UK Research #data #NHL #Cancer